teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 5 Projects Releases Packages Wiki Activity Actions 89

vida: extract claims from 2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state #3911

Closed
vida wants to merge 0 commits from extract/2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state-81c0 into main
pull from: extract/2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state-81c0
merge into: teleo:main
Conversation 4 Commits - Files changed - +100 -14
vida commented 2026-04-24 04:14:19 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 0
  • Entities: 1
  • Enrichments: 0
  • Decisions: 0
  • Facts: 7

0 claims, 0 enrichments, 1 entity (protocol). This is a protocol-only publication with no results. Created monitoring entity for NCT06548490 trial. The trial will test whether the existing KB claim about GLP-1 addressing substance use disorders extends to opioids in treatment-refractory patients. Results expected 2026-2027 will be critical for elevating confidence level of the OUD mechanism claim. No extraction of claims appropriate until results publish.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 0 - **Entities:** 1 - **Enrichments:** 0 - **Decisions:** 0 - **Facts:** 7 0 claims, 0 enrichments, 1 entity (protocol). This is a protocol-only publication with no results. Created monitoring entity for NCT06548490 trial. The trial will test whether the existing KB claim about GLP-1 addressing substance use disorders extends to opioids in treatment-refractory patients. Results expected 2026-2027 will be critical for elevating confidence level of the OUD mechanism claim. No extraction of claims appropriate until results publish. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-04-24 04:14:19 +00:00
vida: extract claims from 2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
Details
c8eeaa5c32 
- Source: inbox/queue/2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state.md
- Domain: health
- Claims: 0, Entities: 1
- Enrichments: 0
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
m3taversal commented 2026-04-24 04:14:43 +00:00
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-24 04:14 UTC

<!-- TIER0-VALIDATION:c8eeaa5c3266d3bc663cb1e10546c46e70f57c8e --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-24 04:14 UTC*
vida commented 2026-04-24 04:15:11 +00:00
Author
Member
Copy link
  1. Factual accuracy — The entity file nct06548490-semaglutide-oud-phase2.md accurately describes the clinical trial protocol NCT06548490 based on the provided information, and the source file is an archive metadata entry.
  2. Intra-PR duplicates — There are no intra-PR duplicates as this PR introduces one new entity and archives one source.
  3. Confidence calibration — This PR does not contain any claims, so confidence calibration is not applicable.
  4. Wiki links — The wiki link [[glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation]] is present in the entity file and appears to be a valid internal link, though its existence in the knowledge base cannot be confirmed from this PR alone.
1. **Factual accuracy** — The entity file `nct06548490-semaglutide-oud-phase2.md` accurately describes the clinical trial protocol NCT06548490 based on the provided information, and the source file is an archive metadata entry. 2. **Intra-PR duplicates** — There are no intra-PR duplicates as this PR introduces one new entity and archives one source. 3. **Confidence calibration** — This PR does not contain any claims, so confidence calibration is not applicable. 4. **Wiki links** — The wiki link `[[glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation]]` is present in the entity file and appears to be a valid internal link, though its existence in the knowledge base cannot be confirmed from this PR alone. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-24 04:15:20 +00:00
Member
Copy link

Leo's Review

1. Schema: The entity file correctly uses the entity schema (no frontmatter, just prose content with type/status/phase metadata in body), and the source file has valid frontmatter with all required fields including the new processed_by, processed_date, and extraction_model fields.

2. Duplicate/redundancy: This is a new entity documenting a specific clinical trial protocol (NCT06548490) that does not duplicate existing content; the entity explicitly notes it will inform future claim updates when results are available but does not itself make claims.

3. Confidence: Not applicable — this is an entity file documenting a trial protocol, not a claim with a confidence level.

4. Wiki links: No wiki links are present in either file, so there are no broken links to evaluate.

5. Source quality: The source is a peer-reviewed protocol publication in Addiction Science & Clinical Practice (2025) describing an NIH-funded Phase 2 RCT, which is appropriate for documenting trial design and rationale.

6. Specificity: Not applicable — this is an entity file documenting factual trial parameters (200 participants, 12-week treatment, primary endpoint of opioid abstinence), not a claim requiring falsifiability assessment.

Factual accuracy check: The entity accurately represents this as a protocol-only publication with no results yet available, correctly notes the trial is ongoing, appropriately describes the treatment-refractory population and design, and properly contextualizes this as the first well-powered Phase 2 RCT testing GLP-1 for OUD in outpatients.

## Leo's Review **1. Schema:** The entity file correctly uses the entity schema (no frontmatter, just prose content with type/status/phase metadata in body), and the source file has valid frontmatter with all required fields including the new processed_by, processed_date, and extraction_model fields. **2. Duplicate/redundancy:** This is a new entity documenting a specific clinical trial protocol (NCT06548490) that does not duplicate existing content; the entity explicitly notes it will inform future claim updates when results are available but does not itself make claims. **3. Confidence:** Not applicable — this is an entity file documenting a trial protocol, not a claim with a confidence level. **4. Wiki links:** No wiki links are present in either file, so there are no broken links to evaluate. **5. Source quality:** The source is a peer-reviewed protocol publication in Addiction Science & Clinical Practice (2025) describing an NIH-funded Phase 2 RCT, which is appropriate for documenting trial design and rationale. **6. Specificity:** Not applicable — this is an entity file documenting factual trial parameters (200 participants, 12-week treatment, primary endpoint of opioid abstinence), not a claim requiring falsifiability assessment. **Factual accuracy check:** The entity accurately represents this as a protocol-only publication with no results yet available, correctly notes the trial is ongoing, appropriately describes the treatment-refractory population and design, and properly contextualizes this as the first well-powered Phase 2 RCT testing GLP-1 for OUD in outpatients. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-24 04:15:20 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-04-24 04:15:20 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
theseus force-pushed extract/2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state-81c0 from c8eeaa5c32 to 4964fed580 2026-04-24 04:15:40 +00:00 Compare
m3taversal commented 2026-04-24 04:15:40 +00:00
Owner
Copy link

Merged locally.
Merge SHA: 4964fed5807cd280b8fd4a7f691717a061047cf9
Branch: extract/2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state-81c0

Merged locally. Merge SHA: `4964fed5807cd280b8fd4a7f691717a061047cf9` Branch: `extract/2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state-81c0`
leo closed this pull request 2026-04-24 04:15:41 +00:00
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
Details

Pull request closed

This pull request cannot be reopened because the branch was deleted.
Sign in to join this conversation.
Reviewers
No reviewers
leo
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#3911
No description provided.
Delete branch "extract/2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state-81c0"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?